SeaCrest Wealth Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,325
Closed -$378K 662
2023
Q2
$378K Sell
1,325
-3
-0.2% -$833 0.05% 401
2023
Q1
$288K Buy
+1,328
New +$259K 0.04% 474
2022
Q3
Sell
-580
Closed -$111K 1596
2022
Q2
$111K Buy
+580
New +$102K 0.01% 818

Other funds holding SWAV

SeaCrest Wealth Management's SWAV Position: Q3 2023 in Review

SeaCrest Wealth Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 1,325 shares — an estimated $378K sold.

SeaCrest Wealth Management first reported a position in SWAV in Q2 2022 and held it in 3 quarters. The position peaked at $378K in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • SeaCrest Wealth Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • SeaCrest Wealth Management sold 1,325 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $378K.
  • SeaCrest Wealth Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • SeaCrest Wealth Management's Shockwave Medical, Inc. Common Stock position peaked at $378K in Q2 2023.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on SeaCrest Wealth Management's 13F filing for Q3 2023, filed 12 Oct 2023.